Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07112105 · ClinicalTrials.gov registry record · NA
Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder
A NA study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT07112105: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT07112105 is a NA study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 106 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07112105, a NA study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
The purpose of this study is to establish a new treatment (repetitive transcranial stimulation (rTMS)) for Veterans with stimulant use disorder (SUD). Despite the large public health burden imposed by SUD, there is currently no FDA-approved or widely recognized effective somatic treatment. This placebo controlled study will test the effectiveness of rTMS in the treatment of SUD, and explore biomarkers that may guide patient selection for rTMS treatment and predict treatment response.
Interventions
- DEVICE Repetitive transcranial magnetic stimulation (rTMS)
- DEVICE Sham rTMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07112105
The ClinicalTrials.gov registry entry for NCT07112105 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Repetitive transcranial magnetic stimulation (rTMS) is the first listed.
NCT07112105 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07112105 about?
NCT07112105 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder". The purpose of this study is to establish a new treatment (repetitive transcranial stimulation (rTMS)) for Veterans with stimulant use disorder (SUD). Despite the large public health burden imposed by SUD, there is currently no FDA-approved or widely recognized effective somatic treatment. This plac...
What is the current status of trial NCT07112105?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 106 participants. The study started on 2026-05-01. Estimated completion is 2029-12-31.
What interventions are being tested in trial NCT07112105?
The interventions under investigation include: Repetitive transcranial magnetic stimulation (rTMS) (DEVICE), Sham rTMS (DEVICE).
Who is sponsoring clinical trial NCT07112105?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.